Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

Samsung Medical Center

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Ischemia

Treatments: Other: Study for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cell

Study type: Interventional

Funder types: Other

Identifiers

NCT00518934

2007-04-064

Details and patient eligibility

About

The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.

Sex: All

Ages: Under 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Patients with ischemic symptoms such as claudication, rest pain or nonhealing ischemic wound

• Without evidence of improvement in response to conventional medical therapy
• Not candidates for surgical intervention or radiologic intervention

Exclusion Criteria:

• Malignant disease
• More than 60 years old
• Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)